Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
11/06/2024 | 22:47 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:VTYX | Ventyx Biosciences Inc |
06/06/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:VTYX | Ventyx Biosciences Inc |
05/06/2024 | 22:01 | GlobeNewswire Inc. | Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers | NASDAQ:VTYX | Ventyx Biosciences Inc |
16/05/2024 | 22:05 | GlobeNewswire Inc. | Ventyx Biosciences to Participate in Three Upcoming Investor Conferences | NASDAQ:VTYX | Ventyx Biosciences Inc |
16/05/2024 | 14:00 | GlobeNewswire Inc. | Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer | NASDAQ:VTYX | Ventyx Biosciences Inc |
09/05/2024 | 22:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:VTYX | Ventyx Biosciences Inc |
09/05/2024 | 22:01 | GlobeNewswire Inc. | Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress | NASDAQ:VTYX | Ventyx Biosciences Inc |
02/05/2024 | 22:05 | GlobeNewswire Inc. | Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024 | NASDAQ:VTYX | Ventyx Biosciences Inc |
26/04/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX | NASDAQ:VTYX | Ventyx Biosciences Inc |
19/04/2024 | 12:00 | PR Newswire (US) | Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYX | NASDAQ:VTYX | Ventyx Biosciences Inc |
16/04/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYX | NASDAQ:VTYX | Ventyx Biosciences Inc |
09/04/2024 | 12:10 | PR Newswire (US) | Investors in Ventyx Biosciences, Inc. Should Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYX | NASDAQ:VTYX | Ventyx Biosciences Inc |
05/04/2024 | 11:45 | PR Newswire (US) | Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact The Gross Law Firm about pending Class Action - VTYX | NASDAQ:VTYX | Ventyx Biosciences Inc |
26/03/2024 | 10:45 | PR Newswire (US) | Ventyx Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - VTYX | NASDAQ:VTYX | Ventyx Biosciences Inc |
11/03/2024 | 12:00 | GlobeNewswire Inc. | Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event | NASDAQ:VTYX | Ventyx Biosciences Inc |
08/03/2024 | 22:05 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:VTYX | Ventyx Biosciences Inc |
07/03/2024 | 14:00 | GlobeNewswire Inc. | Ventyx Biosciences Announces $100 Million Private Placement of Common Stock | NASDAQ:VTYX | Ventyx Biosciences Inc |
07/03/2024 | 11:45 | PR Newswire (US) | Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Seeking Recovery for Investors - Contact The Gross Law Firm | NASDAQ:VTYX | Ventyx Biosciences Inc |
06/03/2024 | 14:00 | GlobeNewswire Inc. | Ventyx Biosciences to Participate in Two Upcoming Investor Conferences | NASDAQ:VTYX | Ventyx Biosciences Inc |
04/03/2024 | 14:00 | GlobeNewswire Inc. | Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024 | NASDAQ:VTYX | Ventyx Biosciences Inc |
27/02/2024 | 22:01 | GlobeNewswire Inc. | Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate Progress | NASDAQ:VTYX | Ventyx Biosciences Inc |
22/02/2024 | 13:00 | GlobeNewswire Inc. | Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002 in Ulcerative Colitis at the 19th Congress of the European Crohn's and Colitis Organisation (ECCO) | NASDAQ:VTYX | Ventyx Biosciences Inc |
13/02/2024 | 22:09 | Edgar (US Regulatory) | Form POSASR - Post-effective Amendment to an automatic shelf registration statement | NASDAQ:VTYX | Ventyx Biosciences Inc |
06/02/2024 | 22:05 | GlobeNewswire Inc. | Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference | NASDAQ:VTYX | Ventyx Biosciences Inc |
02/01/2024 | 22:47 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:VTYX | Ventyx Biosciences Inc |
21/12/2023 | 01:22 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:VTYX | Ventyx Biosciences Inc |
21/11/2023 | 22:05 | GlobeNewswire Inc. | Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare Conference | NASDAQ:VTYX | Ventyx Biosciences Inc |
10/11/2023 | 14:00 | GlobeNewswire Inc. | Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference | NASDAQ:VTYX | Ventyx Biosciences Inc |
09/11/2023 | 22:01 | GlobeNewswire Inc. | Ventyx Biosciences Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Progress | NASDAQ:VTYX | Ventyx Biosciences Inc |
07/11/2023 | 12:33 | IH Market News | Keep An Eye Out: Pre-Market Movers And Analyst Recommendations | NASDAQ:VTYX | Ventyx Biosciences Inc |